Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Human Genome Sciences Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 19
» View latimes.com items only
    May 19, 2013 |Story| Los Angeles Times
  1. Spotlighting a terrorism risk, and profiting

    WASHINGTON — Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a major threat to national security.
    WASHINGTON — Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he...

    Tags: Rockville (Bethlehem, Pennsylvania), National Government, Diseases and Illnesses, National Institutes of Health, Finance

  2. Jul 2, 2012 |Story| Los Angeles Times
  3. GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says

    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil, Wellbutrin and Advair, the U.S. government announced.
    Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...

    Tags: Diabetes, Pharmaceuticals, Trials, Bribery, Corporate Crime

  4. Nov 2, 2009 | Los Angeles Times
  5. Lupus drug Benlysta passes second crucial test

    Booster Shots
    Benlysta, a new drug designed specifically to treat systemic lupus erythematosus, commonly called simply lupus, has passed a second clinical trial, paving the way for it to become the first new treatment approved for lupus in 50 years. Its maker,......
  6. May 20, 2013 |Story| Associated Press
  7. Report: Bio-warfare adviser warned US of threat of new anthrax while on board of drug maker

    WASHINGTON (AP) — Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while serving as a...

    Tags: George W. Bush, Rockville (Bethlehem, Pennsylvania), National Government, Terrorism, U.S. Department of Homeland Security

  8. May 19, 2013 |Story| Los Angeles Times
  9. Timeline: An attorney and anthrax

    May 2001: Washington lawyer Richard J. Danzig is appointed to the board of Human Genome Sciences Inc. in Rockville, Md. Sept. 11, 2001: Terrorists crash passenger jets into the World Trade Center in New York, the Pentagon and rural Pennsylvania. Soon...

    Tags: Rockville (Bethlehem, Pennsylvania), GlaxoSmithKline PLC, U.S. Congress, Anthrax

  10. May 19, 2013 |Story| Los Angeles Times
  11. Pointing to threat, pulling in profit

    Tribune Washington Bureau
    WASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...

    Tags: National Government, Rockville (Bethlehem, Pennsylvania), Diseases and Illnesses, National Institutes of Health, Finance

  12. Oct 17, 2012 |Story| Baltimore Sun
  13. Human Genome to lay off 97 workers

    Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...

    Tags: Rockville (Bethlehem, Pennsylvania), Labor Legislation, Career and Workplace, Layoffs and Downsizing, Job Layoffs

  14. Sep 5, 2012 |Story| Baltimore Sun
  15. Human Genome Sciences announces plan to lay off 114

    Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline. Human Genome, which employs about 1,000 people in Rockville, could...

    Tags: Rockville (Bethlehem, Pennsylvania), Labor Legislation, Career and Workplace, Layoffs and Downsizing, Job Layoffs

  16. Jul 16, 2012 |Story| Baltimore Sun
  17. GlaxoSmithKline to acquire Human Genome Sciences

    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion. GlaxoSmithKline boosted its offer for...

    Tags: Rockville (Bethlehem, Pennsylvania), Diseases and Illnesses, Mergers, Acquisitions and Takeovers, Diabetes, MedImmune Inc.

  18. Jun 8, 2012 |Story| Baltimore Sun
  19. Ripley's opens Odditorium at Harborplace

    Ripley's Believe It or Not, one of the first of several new tenants opening for the summer tourist season at Harborplace in downtown Baltimore, will open Saturday in the Light Street Pavilion. Ripley Entertainment Inc. said exhibits at the Inner Harbor...

    Tags: Inner Harbor, Rockville (Bethlehem, Pennsylvania), Productivity, Media Industry, Benlysta (drug)

  20. Apr 21, 2012 |Story| Baltimore Sun
  21. Consolidation wave poised to hit state's health care services, biopharma sectors

    Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...

    Tags: Rockville (Bethlehem, Pennsylvania), Mergers, Acquisitions and Takeovers, Pharmaceuticals, MedImmune Inc., Healthcare Industry

  22. Dec 31, 2011 |Story| Baltimore Sun
  23. Uncertain year ahead for U.S. stocks

    Investors had plenty to keep them jittery in 2011. There were the earthquake and tsunami in Japan, economic woes in Europe, and, here at home, politically tinged fiscal showdowns in Washington over deep government spending cuts.
    Investors had plenty to keep them jittery in 2011. There were the earthquake and tsunami in Japan, economic woes in Europe, and, here at home, politically tinged fiscal showdowns in Washington over deep government spending cuts. Still, the stock market...

    Tags: Productivity, T. Rowe Price Group Incorporated, Minor League Baseball, Financial Markets, Finance

 1  2Next >
Original site for Human Genome Sciences Inc. topic gallery.
Advertisement
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Human Genome Sciences Inc. Photos
A bottle of Xenical, a weight-loss aid made by GlaxoSmi...
(May 9, 2012)
GlaxoSmithKline launches hostile tender offer for Human Genome Sciences
Steven C. Mayer, Human Genome Sciences' chief financial...
(November 23, 2002)
Steven C. Mayer